|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-11-13
|
|
pubmed:abstractText |
The optimal therapy of oligodendrogliomas remains uncertain. Although chemosensitive, these tumors are not chemocurable. We investigated whether chemotherapy delays the need for radiation therapy (RT) without decreasing length and quality of survival.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0167-594X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
85
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
319-28
|
|
pubmed:dateRevised |
2008-7-2
|
|
pubmed:meshHeading |
pubmed-meshheading:17568995-Adult,
pubmed-meshheading:17568995-Aged,
pubmed-meshheading:17568995-Brain Neoplasms,
pubmed-meshheading:17568995-Cohort Studies,
pubmed-meshheading:17568995-Combined Modality Therapy,
pubmed-meshheading:17568995-Disease-Free Survival,
pubmed-meshheading:17568995-Female,
pubmed-meshheading:17568995-Frontal Lobe,
pubmed-meshheading:17568995-Humans,
pubmed-meshheading:17568995-Male,
pubmed-meshheading:17568995-Middle Aged,
pubmed-meshheading:17568995-Oligodendroglioma,
pubmed-meshheading:17568995-Retrospective Studies,
pubmed-meshheading:17568995-Statistics, Nonparametric,
pubmed-meshheading:17568995-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Role of exclusive chemotherapy as first line treatment in oligodendroglioma.
|
|
pubmed:affiliation |
Radiotherapy and Neuro-Oncology Unit, Centre Léon Bérard, Lyon, France. sunyach@lyon.fnclcc.fr
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
